Valuation
- Market cap
- 6,132,000
- Revenue TTM
- $0
- Net income TTM
- $-4,710,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 3,358,200
- Avg volume
- 125,364
- Day's range
- $4.55 – $4.80
- Shares out
- 1,330,000
- Stochastic %K
- 75%
- Beta
- 1.37
- Analysts
- —
- Price target
- $7.00
Company profile
As of October 1, 2025, Titan Pharmaceuticals, Inc. was acquired by KE Sdn Bhd, in a reverse merger transaction. Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 650 244 4990
- Website
- https://www.titanpharm.com
- Address
- 10 East 53rd St., Suite 3001, New York, United States
Latest news
No headlines yet.
